Skip to content
Screener

Jazz Pharmaceuticals JAZZ Q1 2025 Annual earnings

Reported May 6, 2025 · After market close

Revenue$897.8MMiss by $167.0M
EPS$1.68Miss by $2.83
Revenue estimate$1.1B
EPS estimate$4.51

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$1.2B
EPS estimate$6.47

Financials

Q1 2025

Income statement

See full
Revenue$897.8M-0.5%
Operating income-$55.9M-184%
Net income-$92.5M-533%
EPS (diluted)-$1.52-561%

Balance sheet

See full
Cash & equivalents$1.9B+29.0%
Total debt$5.4B-6.2%
Total equity$4.2B+12.9%
Total assets$11.5B+1.8%

Cash flow

See full
Operating cash flow$429.8M+60.8%
CapEx$13.9M+101%
Free cash flow$415.9M+59.8%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$7.54B+0.1%
Enterprise value$11.08B-6.5%
P/E15.6×-7.1×
P/S1.9×-0.1×

Profitability

See full
Operating margin14.6%+1.1pp
Net margin11.9%+3.3pp
FCF margin37.2%+10.9pp

Returns & leverage

See full
Return on equity12.3%+2.8pp
Debt / equity1.3×-0.3×
Current ratio3.4×+1.1×

Segments

By product

See full
Xywav$344.8M+9.4%
Epidiolex/Epidyolex$217.7M+9.6%
Rylaze/Enrylaze$94.2M-8.3%
Zepzelca$63.0M-16.1%
High-sodium oxybate AG royalty revenue$48.9M-2.1%

By geography

See full
Europe$83.6M+17.2%
All other$16.3M-27.3%

FAQ

When did Jazz Pharmaceuticals report Q1 2025 earnings?
Jazz Pharmaceuticals (JAZZ) reported Q1 2025 earnings on May 6, 2025 after market close.
What were Jazz Pharmaceuticals's Q1 2025 revenue and EPS?
Jazz Pharmaceuticals reported revenue of $897.8M and eps of $1.68 for Q1 2025.
Did Jazz Pharmaceuticals beat estimates in Q1 2025?
Revenue missed the consensus estimate of $1.1B by $167.0M. EPS missed the consensus estimate of $4.51 by $2.83.
How did Jazz Pharmaceuticals's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.5% from $902.0M a year earlier and eps declined 37.3% from $2.68.
Where can I find Jazz Pharmaceuticals's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001232524-25-000025) and the 10-K/A periodic report (0001232524-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.